Interleukina II

Interleukina II may be available in the countries listed below.

Ingredient matches for Interleukina II

Aldesleukin

Aldesleukin is reported as an ingredient of Interleukina II in the following countries:

• Chile

International Drug Name Search

Adipiodone Meglumine

Adipiodone Meglumine may be available in the countries listed below.

Ingredient matches for Adipiodone Meglumine

Adipiodone

Adipiodone Meglumine (BANM) is also known as Adipiodone (Rec.INN)

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tamsulosin 1A Pharma

Tamsulosin 1A Pharma may be available in the countries listed below.

Ingredient matches for Tamsulosin 1A Pharma

Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosin 1A Pharma in the following countries:

• Austria

International Drug Name Search

Palface

Palface may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Palface

Dextromoramide

Dextromoramide tartrate (a derivative of Dextromoramide) is reported as an ingredient of Palface in the following countries:

• Netherlands

International Drug Name Search

Carbavim

Carbavim may be available in the countries listed below.

Ingredient matches for Carbavim

Carbamazepine

Carbamazepine is reported as an ingredient of Carbavim in the following countries:

• Romania

International Drug Name Search

Newmazole

Newmazole may be available in the countries listed below.

Ingredient matches for Newmazole

Carbimazole

Carbimazole is reported as an ingredient of Newmazole in the following countries:

• Taiwan

International Drug Name Search

Naprosyn

Naprosyn is a brand name of naproxen, approved by the FDA in the following formulation(s):

NAPROSYN (naproxen - suspension; oral)

• 
  Manufacturer: ROCHE PALO
  
  Approval date: March 23, 1987
  
  Strength(s): 25MG/ML ^[RLD][AB]

NAPROSYN (naproxen - tablet; oral)

• 
  Manufacturer: ROCHE PALO
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 250MG ^[AB], 375MG ^[AB]


• 
  Manufacturer: ROCHE PALO
  
  Approval date: April 15, 1982
  
  Strength(s): 500MG ^[RLD][AB]

Has a generic version of Naprosyn been approved?

Yes. The following products are equivalent to Naprosyn:

naproxen suspension; oral

• 
  Manufacturer: ROXANE
  
  Approval date: March 30, 1994
  
  Strength(s): 25MG/ML ^[AB]

naproxen tablet; oral

• 
  Manufacturer: AMNEAL PHARMS NY
  
  Approval date: December 18, 2001
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA USA
  
  Approval date: November 8, 2011
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: DAVA PHARMS INC
  
  Approval date: April 28, 1995
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: March 28, 2007
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: INVAGEN PHARMS
  
  Approval date: August 24, 2011
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: MARKSANS PHARMA
  
  Approval date: February 14, 2011
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: December 21, 1993
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: PERRIGO R AND D
  
  Approval date: April 27, 2005
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: December 21, 1993
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: December 21, 1993
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: May 31, 1995
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: WESTWARD
  
  Approval date: January 14, 2004
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA
  
  Approval date: June 7, 2007
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Naprosyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Naprosyn.

See also...

• Naprosyn Consumer Information (Drugs.com)
• Naprosyn Consumer Information (Wolters Kluwer)
• Naprosyn Suspension Consumer Information (Wolters Kluwer)
• Naprosyn Consumer Information (Cerner Multum)
• Naprosyn Advanced Consumer Information (Micromedex)
• Naproxen Consumer Information (Drugs.com)
• Naproxen Consumer Information (Wolters Kluwer)
• Naproxen Enteric-Coated Tablets Consumer Information (Wolters Kluwer)
• Naproxen Suspension Consumer Information (Wolters Kluwer)
• Naproxen Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Naprelan 375 Consumer Information (Cerner Multum)
• Naprelan 500 Consumer Information (Cerner Multum)
• Naprelan 750 Consumer Information (Cerner Multum)
• Naproxen Consumer Information (Cerner Multum)
• Naprelan 500 Advanced Consumer Information (Micromedex)
• Naprelan Dose Card Advanced Consumer Information (Micromedex)
• Naxen Advanced Consumer Information (Micromedex)
• Naproxen Advanced Consumer Information (Micromedex)
• Naproxen AHFS DI Monographs (ASHP)
• Naproxen Sodium AHFS DI Monographs (ASHP)